Depression Treatment Strategies for Primary Care Clinicians
Depression Treatment Strategies for Primary Care Clinicians
Depression, which can range from mild to severe, is a common illness that affects functioning at work and at home. Although the pathophysiology of depression is not fully understood, mechanisms involving neurotransmitters that have traditionally been implicated are now accompanied by neuroplastic pathways that may also mediate human emotion. Whatever the mechanistic pathway(s) that enhance the risk of depression, this condition is a significant public health concern in the United States and primary care clinicians play an important role in both its diagnosis and long-term management. Through this course, participants will explore strategies and tactics for treating depression.
• All participants of the live session will receive a copy of the recording and presentation. The recording and presentation will also be made available as an “On-Demand” course.
• Depression Screening and Diagnosis
• Depression Assessment and Treatment Options
• Strategies for Managing Depression Effectively
• Increase confidence to use a standardized screening and assessment tool effectively.
• Increase confidence to successfully make a differential diagnosis.
• Make accurate assessments of depression severity based on results of a standardized screening and assessment tool.
• Make accurate judgements on the appropriate course of treatment for patients based on depression severity.
• Describe strategies for time management, medication adherence, referrals, and care coordination to improve care for patients with depression.
• Recognize opportunities to apply strategies for time management, medication adherence, referrals, and care coordination into practice.
• Physician assistants.
• Social workers.
• Other members of interdisciplinary health care teams.
• Apply a standardized tool in practice to screen patients for depression.
• Compare and contrast depression with other mental health conditions to make a differential diagnosis and recognize when multiple conditions are co-occurring.
• Determine the severity of a patient’s depression based on results from using a standardized assessment tool.
• Classify recommended pharmacological and non-pharmacological treatment options.
• Based on severity of depression to determine the appropriate course of treatment for a patient.
• Analyze strategies for medication adherence, effective communication, and time management to improve care for patients with depression.
Larry Culpepper, MD
Dr. Culpepper, Professor of Family Medicine, was the founding Chairman of the Department. He received his M.D from Baylor College of Medicine and his M.P.H. from Boston University. He has served as President of the North American Primary Care Group (NAPCRG), Chairman of the Research Committee of the Society of Teachers of Family Medicine (STFM), and is the Chairman of the Board of Rhode Island Public Health Foundation. He is a Primary Care Fellow of the Federal Health Resources and Services Administration, and has chaired or served as a member of research grant review committees for 5 NIH and other federal agencies. He has received the STFM Excellence in Education, the STFM-NAPCRG Hames Research awards, and the Maurice Wood Award for Lifetime Contribution to Primary Care Research (2010) and was elected to the Institute of Medicine in 1998. The BU School of Public Health recognized him with its 2008 BUSPH Distinguished Alumni Award.
Dr. Culpepper has conducted research in otitis media, and school-based and community interventions to improve pregnancy outcomes and to prevent teen pregnancies and has been the principal investigator of an AHRQ funded center for patient safety research devoted to low income and minority vulnerable populations in ambulatory care settings, principal investigator of interventions to improve the care of uninsured patients and urban patients with diabetes and depression, co-principal investigator of a study to decrease delays in CHC patient follow-up for abnormal mammography, and co-investigator of a long term study of the course of anxiety disorders in primary care settings. Dr Culpepper co-chaired a panel on Otitis Media with Effusion for the American Academy of Family Physicians, the American Academy of Pediatrics, and the American Academy of Otolaryngology-Head and Neck Surgery, and is a member of the AAP-AAFP panel on acute otitis media. He founded and chaired the board of the Rhode Island Public Health Foundation (1992-2011). He is a member of The Depression and Bipolar Support Alliance and the Anxiety Disorders Association of America Scientific Advisory Boards. He currently is the primary care member of an Institute of Medicine Committee on the Assessment of Ongoing Efforts in the Treatment of PTSD (2011-15). He was the initial family medicine editor of UpToDate and is the editor of the Journal of Clinical Psychiatry Primary Care Companion.
In support of improving patient care, the National Committee for Quality Assurance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), the American Academy of Physician Assistants (AAPA), the American Psychological Association (APA), and the Association of Social Work Boards (ASWB) to provide Interprofessional Continuing Education for the healthcare team.
This educational activity is approved for a maximum of 1.0 AMA PRA Category 1 Credit™.
This educational activity is approved for 1.0 nursing contact hours.*
This live course grants 1.0 Continuing Education Unit (CEU) points for PCMH Certified Content Experts.
* Please note – You must attend the entire program to be eligible for total number of contact hours.
Disclosure of Relevant Financial Relationships
The National Committee for Quality Assurance (NCQA) endorses the Standards of the Accreditation Council for Continuing Medical Education which specify that sponsors of continuing medical education activities and presenters at and planners for these activities disclose any relevant financial relationships either party might have with commercial companies whose products or services are discussed in educational presentations.
For sponsors, relevant financial relationships include large research grants, institutional agreements for joint initiatives, substantial gifts, or other relationships that benefit the institution. For presenters or planning committee members, relevant financial relationships include the receipt of research grants from a commercial company, consultancies, honoraria, travel, or other benefits, or having a self-managed equity interest in a company; or having an immediate family member or partner with such a relationship.
Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Relevant financial relationships exist with the following companies/organizations:
Larry Culpepper: None
Additional Planning Committee Members:
This program was developed in part by NCQA staff.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
- 1.00 PCMH CCE